证券代码：002141 证券简称：贤丰控股 公告编号：2025-071 贤丰控股股份有限公司 关于证券事务代表辞职的公告 温秋萍女士已完成所负责相关工作的交接，其辞职不会对公司相关工作及生 产经营产生影响。公司将按照相关规定，尽快聘任符合任职资格的人员担任证券 事务代表，协助董事会秘书开展工作。 特此公告。 贤丰控股股份有限公司 董事会 2025 年 9 月 12 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 贤丰控股股份有限公司（以下简称"公司"）董事会近日收到公司证券事务 代表温秋萍女士的书面辞职报告。温秋萍女士因个人原因辞去公司证券事务代表 职务。辞职后，温秋萍女士不再担任公司任何职务。温秋萍女士的辞职报告自送 达公司董事会之日起生效。截至本公告日，温秋萍女士未持有公司股份。 公司及公司董事会对温秋萍女士任职期间的勤勉工作及对公司发展作出的贡 献表示衷心感谢！ ...

Market Overview - The animal health sector experienced a decline of 0.21% on September 12, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3883.69, up 0.22%, while the Shenzhen Component Index closed at 12996.38, up 0.13% [1] Individual Stock Performance - Shunlian Biological (688098) closed at 11.85, up 2.07% with a trading volume of 85,100 shares and a turnover of 99.05 million yuan [1] - KQ Biological (688526) closed at 18.63, up 0.70% with a trading volume of 19,700 shares and a turnover of 36.27 million yuan [1] - Huisheng Biological (300871) closed at 22.55, up 0.53% with a trading volume of 54,100 shares and a turnover of 122 million yuan [1] - Dayu Biological (871970) led the decline, closing at 10.73, down 3.85% with a trading volume of 76,600 shares and a turnover of 82.31 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 15.44 million yuan from institutional investors, while retail investors experienced a net outflow of 9.04 million yuan [2] - Speculative funds recorded a net inflow of 24.47 million yuan [2] Detailed Capital Flow for Selected Stocks - Shunlian Biological had a net inflow of 14.94 million yuan from institutional investors, but a net outflow of 21.09 million yuan from retail investors [3] - Huisheng Biological experienced a net outflow of 7.83 million yuan from institutional investors, while retail investors had a net inflow of 9.81 million yuan [3] - KQ Biological saw a net outflow of 1.73 million yuan from institutional investors, with a minor net inflow from retail investors [3]

Core Viewpoint - The animal health sector experienced a rise of 0.92% on September 11, with Dayu Biological leading the gains, while the overall market indices also showed significant increases [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3875.31, up 1.65%, and the Shenzhen Component Index closed at 12979.89, up 3.36% [1]. - Dayu Biological's stock price increased by 3.81% to 11.16, with a trading volume of 140,500 shares and a transaction value of 158 million [1]. Group 2: Individual Stock Performance - Other notable performers included: - Houfeng Holdings, up 2.75% to 4.11, with a trading volume of 326,800 shares and a transaction value of 133 million [1]. - Keqian Biological, up 2.15% to 18.50, with a trading volume of 32,400 shares and a transaction value of 59.27 million [1]. - Yongshun Biological, up 1.69% to 10.80, with a trading volume of 48,100 shares and a transaction value of 52.46 million [1]. Group 3: Capital Flow Analysis - The animal health sector saw a net outflow of 70.71 million from institutional investors, while retail investors contributed a net inflow of 77.65 million [2][3]. - The capital flow for individual stocks showed varied trends, with significant outflows from stocks like Zhongmu Co., which had a net outflow of 11.86 million from institutional investors [3].

Meeting Details - The meeting was held on September 5, 2025, at 15:00, with online voting available from 9:15 to 11:30 on the same day [1] - A total of 3 shareholders attended the meeting in person, representing 117,310,747 shares (14.2917% of total voting shares), while 341 shareholders participated via online voting, representing 5,694,900 shares (0.6938% of total voting shares) [1][2] Voting Results - The total voting results showed that 122,292,647 shares were in favor of the proposals, accounting for 99.4204% of the valid votes cast [2] - Among small shareholders, 4,982,000 shares voted in favor, representing 87.4802% of the small shareholder votes [3] - The overall voting results indicated that 122,323,047 shares were in favor, which is 99.4451% of the valid votes [4] Legal Compliance - The meeting was witnessed by lawyers from Shanghai Jintiancheng (Shenzhen) Law Firm, who confirmed that the meeting's procedures and voting processes complied with relevant laws and regulations [11]

Core Viewpoint - The legal opinion letter confirms that the convening and holding of the 2025 Second Extraordinary General Meeting of Shareholders of Xianfeng Holdings Co., Ltd. complies with relevant laws and regulations, ensuring the legitimacy and validity of the meeting and its resolutions [1][14]. Group 1: Meeting Organization - The meeting was convened by the company's board of directors, with the decision made on August 19, 2025 [2][3]. - The notice for the meeting was published on August 21, 2025, meeting the requirement of being announced at least 15 days prior to the meeting date [3]. Group 2: Attendance and Voting - A total of 344 shareholders and their proxies attended the meeting, representing 123,005,647 shares, which is 14.9855% of the total voting shares [5]. - Among the attendees, 3 shareholders represented 117,310,747 shares, accounting for 14.2917% of the total shares [5]. - The meeting utilized both on-site and online voting methods, with online voting available from 9:15 AM to 3:00 PM on September 5, 2025 [3][4]. Group 3: Voting Results - The voting results indicated that the first and second items on the agenda were passed with significant support, with 122,292,647 shares voting in favor, representing a majority of the votes cast [7]. - The small investors' voting results showed that 87.4802% of the small shareholders voted in favor of the proposals [7]. - The voting process was conducted in accordance with legal requirements, and all resolutions were deemed valid [14].

Group 1 - The company held the 20th meeting of the 8th Board of Directors on August 19, 2025, and the second extraordinary general meeting of shareholders on September 5, 2025, where several proposals were approved, including changes to the registered address and business scope, as well as amendments to the company's articles of association and various management systems [1][2] - The company no longer has a supervisory board, and the responsibilities of the supervisory board have been transferred to the audit committee of the board of directors [2] - The company expressed gratitude to the former supervisors for their contributions to the company's development during their tenure [2]

证券代码：002141 证券简称：贤丰控股 公告编号：2025-070 贤丰控股股份有限公司 关于公司制度修订及制定已生效的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 贤丰控股股份有限公司（以下简称"公司"）分别于 2025 年 8 月 19 日召开 第八届董事会第二十次会议、2025 年 9 月 5 日召开 2025 年第二次临时股东大会 审议通过了《关于变更注册地址和经营范围并修订<公司章程>的议案》、《关 于修订公司部分制度的议案》、《董事、高级管理人员薪酬管理制度》（2025 年 8 月），同意公司修订部分制度及制定制度，公司不再设置监事会，公司 2025 年 8 月 21 日在巨潮资讯网（www.cninfo.com.cn）披露的下列制度已生效：《公司 章程》（2025 年 8 月）、《董事会议事规则》（2025 年 8 月）、《股东会议事 规则》（2025 年 8 月）、《募集资金管理制度》（2025 年 8 月）、《对外投资 管理制度》（2025 年 8 月）、《独立董事工作制度》（2025 年 8 月）、《关联 交易决策制度》（202 ...

上海市锦天城（深圳）律师事务所 关于贤丰控股股份有限公司 2025 年第二次临时股东大会的 法律意见书 地址：深圳市福田中心区福华三路卓越世纪中心 1 号楼 21、22、23 层 电话：0755-82816616 传真：0755-82816898 邮编：518048 上海市锦天城（深圳）律师事务所 法律意见书 上海市锦天城（深圳）律师事务所 关于贤丰控股股份有限公司 2025 年第二次临时股东大会的 法律意见书 致：贤丰控股股份有限公司 上海市锦天城（深圳）律师事务所（以下简称"本所"）接受贤丰控股股份 有限公司（以下简称"公司"）委托，就公司召开 2025 年第二次临时股东大会 （以下简称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以 下简称《公司法》）《上市公司股东会规则》等法律、法规、规章和其他规范性 文件以及《贤丰控股股份有限公司章程》（以下简称《公司章程》）的有关规定， 出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1．本次股东大会未出现否决议案的情形。 2．本次股东大会未出现新提案提交表决的情形。 证券代码：002141 证券简称：贤丰控股 公告编号：2025-069 贤丰控股股份有限公司 2025 年第二次临时股东大会决议公告 （一）会议召开情况 3．本次股东大会不涉及变更以往股东大会决议的情形。 一、会议召开和出席情况 1.会议召开的日期、时间： （1）现场会议召开时间：2025 年 9 月 5 日下午 15:00。 （2）网络投票时间为：2025 年 9 月 5 日。其中：通过深圳证券交易所交易 系统进行网络投票的具体时间为 2025 年 9 月 5 日 9:15—9:25、9:30—11:30、 13:00—15:00；通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 9 月 5 日 9:15—15:00 期间的任意时间。 2.现场会议地点：东莞市南城街道东莞大道南城段 428 号寰宇汇金中心 6 栋 17 层 008 号。 3.会议的召开方式：现场投票与网络投票相结合的方式。 4.会议召 ...

Market Overview - The animal health sector increased by 1.25% on September 5, with Yongshun Biological leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Stock Performance - Yongshun Biological (839729) closed at 10.82, up 4.14% with a trading volume of 44,500 shares and a turnover of 47.80 million yuan [1] - Shilian Biological (688098) closed at 11.76, up 3.16% with a trading volume of 114,100 shares and a turnover of 132 million yuan [1] - Other notable performers include: - Houfeng Holdings (002141): closed at 3.96, up 2.33% [1] - KQ Biological (688526): closed at 18.00, up 2.16% [1] - Dayu Biological (871970): closed at 10.25, up 2.09% [1] Capital Flow - The animal health sector experienced a net outflow of 37.19 million yuan from institutional investors, while retail investors saw a net inflow of 13.24 million yuan [2] - Notable capital flows include: - Shilian Biological: net inflow of 500.11 thousand yuan from institutional investors [3] - Houfeng Holdings: net inflow of 91.15 thousand yuan from retail investors [3] - KQ Biological: net outflow of 297.54 thousand yuan from institutional investors [3]